These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6987167)

  • 21. Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines.
    Lindberg AA; Robertsson JA
    Infect Immun; 1983 Aug; 41(2):751-7. PubMed ID: 6347896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
    Venneman MR; Berry LJ
    Infect Immun; 1971 Oct; 4(4):374-80. PubMed ID: 4949497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
    Venneman MR; Berry LJ
    Infect Immun; 1971 Oct; 4(4):381-7. PubMed ID: 4949498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early antibody response in mice to either infection or immunization with Salmonella typhimurium.
    Kenny K; Herzberg M
    J Bacteriol; 1967 Mar; 93(3):773-8. PubMed ID: 5337833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.
    Angerman CR; Eisenstein TK
    Infect Immun; 1980 Feb; 27(2):435-43. PubMed ID: 6991415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice.
    Ervin SE; Small PA; Gulig PA
    Microb Pathog; 1993 Aug; 15(2):93-101. PubMed ID: 8255210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SipD and IpaD induce a cross-protection against Shigella and Salmonella infections.
    Jneid B; Rouaix A; Féraudet-Tarisse C; Simon S
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008326. PubMed ID: 32463817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. II. Isolation and characterization of the protective moiety in the dialyzable factor.
    Kita E; Tsukao N; Kitajima S; Takahashi S; Kashiba S
    Microbiol Immunol; 1983; 27(2):117-30. PubMed ID: 6346025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.
    Killion JW; Morrison DC
    Infect Immun; 1986 Oct; 54(1):1-8. PubMed ID: 3531011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of transfer RNA isolated from a two-heptose rough mutant of Salmonella typhimurium LT2 in mouse typhoid infection.
    Kita E; Kashiba S
    Immunology; 1983 Nov; 50(3):369-76. PubMed ID: 6195095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.
    Svenson SB; Nurminen M; Lindberg AA
    Infect Immun; 1979 Sep; 25(3):863-72. PubMed ID: 387597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
    Nickol AD; Bonventre PF
    J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity conferred by Aro- Salmonella live vaccines.
    Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
    Microb Pathog; 1991 Feb; 10(2):149-58. PubMed ID: 1890952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.
    Lin JH; Berry LJ
    J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of immune responses in genital tracts of mice immunised with purified ribosomal fractions of Neisseria gonorrhoeae.
    Kita E; Kashiba S
    Br J Vener Dis; 1984 Aug; 60(4):219-25. PubMed ID: 6430462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteins from Salmonella R-mutants mediating protection against Salmonella typhimurium infection in mice. II. Protection tests performed with proteins free from lipopolysaccharide.
    Schlecht S; Bhatnagar N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 May; 259(3):367-77. PubMed ID: 3901613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein.
    Poirier TP; Kehoe MA; Beachey EH
    J Exp Med; 1988 Jul; 168(1):25-32. PubMed ID: 3294331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.
    Tewari RP; Lynn M; Birnbaum AJ; Solotorovsky M
    Infect Immun; 1978 Jan; 19(1):58-65. PubMed ID: 304844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.
    Kita E; Emoto M; Yasui K; Yasui K; Katsui N; Nishi K; Kashiba S
    Immunology; 1986 Mar; 57(3):431-5. PubMed ID: 3514442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.